Antigeno recombinante la glicoproteina e del virus la varicela zoster

Shingrix Suspension Inyectable en Jeringa Precargada

50 µg suspensión inyectable en jeringa precargadaSpainAuthorisedAuthorised 10 Sept 2026

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

ShingrixEuropean UnionAuthorised

Packs

Pack	Code	Status
SHINGRIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA, 10 jeringas pregargadas de 0,5 ml	607996
SHINGRIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,5 ml	771928

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Antigeno recombinante la glicoproteina e del virus la varicela zoster

Shingrix Suspension Inyectable en Jeringa Precargada

50 µg suspensión inyectable en jeringa precargadaSpainAuthorisedAuthorised 10 Sept 2026

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

ShingrixEuropean UnionAuthorised

Packs

Pack	Code	Status
SHINGRIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA, 10 jeringas pregargadas de 0,5 ml	607996
SHINGRIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,5 ml	771928

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

AEMPS

Register entryAEMPS

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Antigeno recombinante la glicoproteina e del virus la varicela zoster
Strength: 50 µg
Dosage form: suspensión inyectable en jeringa precargada
Route: vía intramuscular
Register: Spain (AEMPS)
Status: Authorised
Status in the register: Autorizado, no comercializado
Authorised: 10 Sept 2026
Registration: 1181272003
Marketing authorisation holder: Glaxosmithkline Biologicals
Procedure: EU centralised
Supply: Medicamento Sujeto A Prescripción Médica
EU number: EU/1/18/1272